Skip to main content
Top
Published in: Gastric Cancer 2/1999

01-08-1999 | Original article

Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancer

Authors: Jianhui Cai, Masahide Ikeguchi, Michio Maeta, Nobuaki Kaibara, Takashi Sakatani

Published in: Gastric Cancer | Issue 2/1999

Login to get access
Metadata
Title
Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancer
Authors
Jianhui Cai
Masahide Ikeguchi
Michio Maeta
Nobuaki Kaibara
Takashi Sakatani
Publication date
01-08-1999
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 2/1999
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s101200050030

Other articles of this Issue 2/1999

Gastric Cancer 2/1999 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine